Camp4 Therapeutics Corporation · NASDAQ:CAMP
Mandel-Brehm Josh bought 6,551 Camp4 Therapeutics Corporation shares (Form 4)
Traded Aug 3, 2026 · Filed Aug 5, 2026
On Aug 3, 2026, Mandel-Brehm Josh (Director, Chief Executive Officer) bought 6,551 Camp4 Therapeutics Corporation shares at US$1.65 for US$10,809, leaving 284,968 shares. Filed Aug 5, 2026 (Form 4).
- Bought
- 6,551 shares
- Price
- US$1.65
- Value
- US$10,809
- Holding after
- 284,968 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Buy | 6,551 | US$1.65 | 284,968 | Direct |